SCHEMBL11359486

SCHEMBL11359486

O=S(=O)(O)CCS(=O)(=O)O.[BaH2]

nearest known ligand 0.56

Known targets — ChEMBL curated mechanism

DRD2

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.56
PDE4A P27815 1/20 0.56
LMNA P02545 1/20 0.56
SLC6A6 P31641 1/20 0.56
CYP2C19 P33261 1/20 0.56
BLM P54132 1/20 0.56
APP P05067 1/20 0.50
CA5A P35218 2/20 0.42
CA5B Q9Y2D0 2/20 0.42
TSHR P16473 3/20 0.36
CA2 P00918 2/20 0.36
CA1 P00915 1/20 0.36
NT5E P21589 1/20 0.36
CA4 P22748 1/20 0.36
CA6 P23280 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21777928 0.95 PTGS1 (0.60) PTGS1PDE4ALMNASLC6A6CYP2C19
SCHEMBL2622 0.95 PTGS1 (0.60) PTGS1PDE4ALMNASLC6A6CYP2C19
SCHEMBL2521154 0.91 PTGS1 (0.56) PTGS1PDE4ALMNASLC6A6CYP2C19
SCHEMBL2524419 0.91 PTGS1 (0.56) PTGS1PDE4ALMNASLC6A6CYP2C19
Ammonia Solution, Strong SCHEMBL5763087 0.91 PTGS1 (0.56) PTGS1PDE4ALMNASLC6A6CYP2C19
Hydrochloric Acid SCHEMBL14053301 0.91 PTGS1 (0.56) PTGS1PDE4ALMNASLC6A6CYP2C19
SCHEMBL2288880 0.91 PTGS1 (0.56) PTGS1PDE4ALMNASLC6A6CYP2C19
SCHEMBL20607658 0.91 PTGS1 (0.56) PTGS1PDE4ALMNASLC6A6CYP2C19
Water SCHEMBL162527 0.91 PTGS1 (0.56) PTGS1PDE4ALMNASLC6A6CYP2C19
Ammonia Solution, Strong SCHEMBL5760499 0.91 PTGS1 (0.56) PTGS1PDE4ALMNASLC6A6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0000219-B1 MACROCYCLIC POLYETHER COMPLEXES AND A PROCESS FOR THE ISOLATION OF MACROCYCLIC POLYETHERS SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1981-09-23 EP claimed
US-4199513-A SAFER METHOD OF ISOLATING CROWN ETHERS SHELL OIL COMPANY (US) 1980-04-22 US claimed
EP-0000219-A1 Macrocyclic polyether complexes and a process for the isolation of macrocyclic polyethers SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1979-01-10 EP claimed
US-12129239-B2 Method for producing methylene disulfonate compound SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2024-10-29 US disclosed
EP-4006020-B1 METHOD FOR PRODUCING CYCLIC DISULFONIC ACID ESTER COMPOUND SUMITOMO SEIKA CHEMICALS (JP) 2024-09-25 EP disclosed
CN-114144407-B Process for producing cyclic disulfonate compound 住友精化株式会社 2024-02-13 CN disclosed
US-11802119-B2 Method for producing cyclic disulfonic acid ester compound SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2023-10-31 US disclosed
US-20220251060-A1 METHOD FOR PRODUCING CYCLIC DISULFONIC ACID ESTER COMPOUND SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2022-08-11 US disclosed
US-20220251059-A1 METHOD FOR PRODUCING METHYLENE DISULFONATE COMPOUND SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2022-08-11 US disclosed
EP-4006020-A1 METHOD FOR PRODUCING CYCLIC DISULFONIC ACID ESTER COMPOUND Sumitomo Seika Chemicals Co., Ltd. (JP) 2022-06-01 EP disclosed
EP-4006019-A1 METHOD FOR PRODUCING METHYLENE DISULFONATE COMPOUND Sumitomo Seika Chemicals Co., Ltd. (JP) 2022-06-01 EP disclosed
WO-2021015219-A1 METHOD FOR PRODUCING METHYLENE DISULFONATE COMPOUND 住友精化株式会社 2021-01-28 WO disclosed
EP-2610250-B1 METHOD FOR PRODUCING A METHYLENE DISULFONATE COMPOUND SUMITOMO SEIKA CHEMICALS (JP) 2016-01-20 EP disclosed
US-8501966-B2 Method for producing a methylene disulfonate compound SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2013-08-06 US disclosed
EP-2610250-A1 METHOD FOR PRODUCING A METHYLENE DISULFONATE COMPOUND Sumitomo Seika Chemicals Co. Ltd. (JP) 2013-07-03 EP disclosed
US-20130137881-A1 METHOD FOR PRODUCING A METHYLENE DISULFONATE COMPOUND SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2013-05-30 US disclosed
CN-103080099-A Method for producing a methylene disulfonate compound SUMITOMO SEIKA CHEMICALS 2013-05-01 CN disclosed
EP-0000219-B1 MACROCYCLIC POLYETHER COMPLEXES AND A PROCESS FOR THE ISOLATION OF MACROCYCLIC POLYETHERS SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1981-09-23 EP disclosed
US-4199513-A SAFER METHOD OF ISOLATING CROWN ETHERS SHELL OIL COMPANY (US) 1980-04-22 US disclosed
EP-0000219-A1 Macrocyclic polyether complexes and a process for the isolation of macrocyclic polyethers SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1979-01-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12129239-B2 Method for producing methylene disulfonate compound TST, MPST, SQOR PTGS1 1297/4885PDE4A 4430/4885LMNA 4690/4885
US-20220251060-A1 METHOD FOR PRODUCING CYCLIC DISULFONIC ACID ESTER COMPOUND STS, TST, SCLY PTGS1 1684/4885PDE4A 3360/4885LMNA 4732/4885
US-20220251059-A1 METHOD FOR PRODUCING METHYLENE DISULFONATE COMPOUND TST, MPST, SQOR PTGS1 1297/4885PDE4A 4430/4885LMNA 4690/4885
US-20130137881-A1 METHOD FOR PRODUCING A METHYLENE DISULFONATE COMPOUND DHPS, ADH7, MPST PTGS1 1332/4885PDE4A 4339/4885LMNA 4415/4885
US-11802119-B2 Method for producing cyclic disulfonic acid ester compound STS, TST, SCLY PTGS1 1684/4885PDE4A 3360/4885LMNA 4732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.